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Abstract  The  basic  function  of  the  gallbladder  in  humans  is  one  of  protection.  The  accumula-
tion of  the  primary  bile  acids  (cholic  acid  and  chenodeoxycholic  acid)  in  the  gallbladder  reduces
the formation  of  the  secondary  bile  acids  (deoxycholic  acid  and  lithocholic  acid),  thus  dimin-
ishing their  concentration  in  the  so-called  gallbladder-independent  enterohepatic  circulation
and protecting  the  liver,  the  stomach  mucosa,  the  gallbladder,  and  the  colon  from  their  toxic
hydrophobic  effects.  The  presence  or  absence  of  the  gallbladder  in  mammals  is  a  determining
factor in  the  synthesis  of  hydrophobic  or  hydrophilic  bile  acids.  Because  the  gallbladder  con-
tracts 5--20  min  after  food  is  in  the  stomach  and  the  ‘‘gastric  chyme’’  moves  from  the  stomach
to the  duodenum  1--3  h  later,  the  function  of  the  gallbladder  bile  in  digestion  may  be  insigniﬁ-
cant. The  aim  of  this  article  was  to  provide  a  detailed  review  of  the  role  of  the  gallbladder  and
the mechanisms  related  to  bile  formation  in  humans.
© 2012  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.  All
rights reserved.
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El  papel  de  la  vesícula  biliar  en  los  humanos
Resumen  La  función  básica  de  la  vesícula  biliar  en  el  ser  humano  es  de  protección.  Medi-
ante la  acumulación  de  los  ácidos  biliares  primarios  (ácidos  cólico  y  quenodesoxicólico)  en
la vesícula  biliar,  se  disminuye  la  formación  secundaria  de  ácidos  biliares  hidrófobos  tóxicos
(ácidos desoxicólico  y  litocólico),  lo  que  reduce  su  concentración  en  la  vesícula  de  forma
independiente  de  la  circulación  enterohepática  y  protege  al  hígado,  la  mucosa  del  estómago,enterohepática;
Lipoproteínas;
Cálculos  biliares;
Colecistectomía;
Cáncer
la vesícula  biliar,  y  el  colon  de  sus  efectos.  En  los  mamíferos  la  presencia  o  ausencia  de
la vesícula  biliar  es  determinante  para  la  síntesis  de  ácidos  biliares  hidrófobos  o  hidróﬁlos,
respectivamente.  Debido  a  que  la  vesícula  biliar  se  contrae  5-20  min  después  de  que  los  ali-
mentos están  disponibles  en  el  estómago,  y  «el  quimo  gástrico» se  mueve  desde  el  estómago
hasta el  duodeno  solamente  1-3  h  más  tarde,  la  función  de  la  vesícula  biliar  en  la  digestión  es
∗ Corresponding author at: Department of Experimental Surgery, State Establishment Scientiﬁc Centre of Reconstructive and Restorative
Surgery, Siberian Branch, Russian Academy of Medical Sciences, Yubileyniy 100, Irkutsk 664079, Russia.
E-mail address: drjacobturumin@yahoo.com (J.L. Turumin).
0375-0906/$ –  see front matter © 2012 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. All rights reserved.
http://dx.doi.org/10.1016/j.rgmx.2013.02.003
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realmente  mínima.  El  objetivo  de  esta  revisión  es  hacer  una  revisión  detallada  del  papel  de  la
vesícula biliar  y  los  mecanismos  relacionados  con  la  formación  de  bilis  en  el  humano.
© 2012  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Todos los  derechos  reservados.
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ihe inﬂuence of the functions of the
allbladder on the process of gallbladder bile
ormation and enterohepatic circulation
unctions  of  the  gallbladder
he  prevalent  point  of  view  is  that  the  gallbladder  is
ot  essential  for  life.1 The  gallbladder  has  the  functions
f  absorption,  concentration,  secretion,  and  evacuation.2,3
he  absorption  and  concentration  functions  are  interdepen-
ent.  The  absorption  function  of  the  gallbladder  includes
he  absorption  of  water,  Na+,  cholesterol,  phospholipids,
ydrophilic  proteins,  etc.4--14 Since  the  absorption  of  the  bile
cids  by  the  gallbladder  mucosa  is  2--6%  of  the  total  concen-
ration  in  the  gallbladder  bile,  the  concentration  function  of
he  gallbladder  consists  of  accumulating  the  bile  acids  from
he  hepatic  bile  in  the  gallbladder.10--12,15,16 The  secretion
unction  of  the  gallbladder  includes  the  secretion  of  glyco-
rotein  mucin  by  the  gallbladder  mucosa,  H+ ions,  Cl−,  and
robably  immunoglobulins  and  Ca2+.5,17--23
onceptual  model  of  gallbladder  bile  formation
onsidering  the  fact  that  the  detailed  structuring  of  the
rocess  of  hepatic  bile  entering  the  gallbladder  has  not
een  worked  out,  we  have  introduced  two  new  terms  into
ractice:  the  ‘‘active’’  and  ‘‘passive’’  passages  of  the
epatic  bile.  The  ‘‘active’’  passage  depends  on  the  ejection
olume  of  the  gallbladder  after  a  meal  or  during  the  interdi-
estive  period.  The  ‘‘passive’’  passage  is  connected  with  the
ate  of  water  absorption  in  the  gallbladder.  Hence  the  rate  of
he  hepatic  bile  entering  the  gallbladder  contains  both  the
‘active’’  and  ‘‘passive’’  passages.  During  the  ‘‘active’’  pas-
age  only  one  volume  (out  of  6--9)  of  the  hepatic  bile  enters
gainst  5--8  volumes  during  the  ‘‘passive’’  passage.  The  rate
f  hepatic  bile  entering  the  gallbladder  depends  on  the  rate
f  water  absorption  by  the  gallbladder  mucosa  (r  =  +0.99,
 <  0.001).24 The  rate  of  water  absorption  by  the  gallbladder
ucosa  is  up  to  100--250  l/min;  sometimes  it  may  increase
p  to  500  l/min.4 The  rate  of  hepatic  bile  entering  the  gall-
ladder  is  75%  of  the  basal  secretion  of  hepatic  bile.24 It  is
ndirectly  conﬁrmed  by  the  fact  that  78  ±  10%  of  the  bile
cids  from  the  total  bile  acid  pool  are  accumulated  in  the
allbladder.25 The  concentration  of  total  bile  acids  in  the
allbladder  bile  depends  on  the  rate  of  bile  acids  from  the
epatic  bile  entering  the  gallbladder  (r  =  +0.87,  p  <  0.001).24
etailed  structuring  of  the  process  of  hepatic  bile  entering
he  gallbladder  suggests  that  83--89%  of  the  bile  acids  con-
ained  in  the  gallbladder  bile  enters  during  the  ‘‘passive’’
assage,  and  only  11--17%  of  the  bile  acids  enter  during  the
‘active’’  passage.  Hence,  the  ‘‘passive’’  passage  of  the
p
a
(
cepatic  bile  into  the  gallbladder  plays  an  important  role  in
he  mechanism  of  gallbladder  bile  formation  (Fig.  1a).
Normally  the  ﬁlling  process  of  the  gallbladder  after  the
ntravenous  introduction  of  X-ray  contrast  is  characterized
y  some  regular  features.26 During  the  ﬁrst  15--20  min  the
allbladder  bile  has  two  layers:  the  upper  contrasting  and
he  lower  non-contrasting  (Fig.  1a).  The  legible  border
etween  them  is  situated  horizontally.  During  the  30--40th
inute,  the  upper  layer  contrasting  the  bile  near  the  wall
hickens,  its  density  grows  because  of  the  presence  of
eavy  iodine  atoms,  and  exceeds  the  density  of  the  non-
ontrasting  concentrated  bile.  In  addition,  the  ‘‘heavy’’
ayers  of  the  contrasting  bile  begin  to  trickle  down  along
he  walls,  as  if  ﬂowing  around  the  non-contrasting  concen-
rated  bile,  and  accumulate  at  the  fundus  (Fig.  1b).  The
allbladder  shadow  becomes  three-layered:  the  contrasting,
ut  unconcentrated  bile  is  above;  the  concentrated,  but
on-contrasting  bile  is  underneath;  and  the  contrasting  and
oncentrated  bile  is  beyond  the  lower  part  of  gallblad-
er.  The  boundary  between  them  is  legible  and  it  does
ot  change  if  the  patient  moves.  The  quantity  of  the  con-
entrated  contrasting  bile  at  the  fundus  of  the  gallbladder
ncreases  gradually,  and  the  upper  boundary  of  the  lower
ayer  rises  (Fig.  1c).  The  gallbladder  shadow  gains  homo-
eneity  2.5--3.0  h  after  the  contrast  medium  is  introduced
Fig.  1d).26
Therefore,  in  a  nighttime  fasting  state  or  in  an  interdi-
estive  state,  the  absorption  of  water  by  the  infundibulum
ucosa  of  the  gallbladder  plays  the  leading  role  in  gallblad-
er  bile  formation  (unpublished  data).
echanism  of  gallbladder  bile  formation
wo  points  in  the  process  of  gallbladder  bile  formation
hould  be  distinguished:  (1)  in  a fasting  stomach  and  (2)
fter  postprandial  gallbladder  emptying.24 The  absorbing
nd  concentrating  functions  determine  the  mechanism  of
he  gallbladder  bile  formation.
The  rate  of  biliary  cholesterol  absorption  by  the  gallblad-
er  mucosa  depends  on  the  concentration  of  the  cholesterol
n  the  gallbladder  bile  (r  =  +0.60,  p  <  0.001).7--9 Taking  into
ccount  the  fact  that  the  mixed  (bile  acids-phospholipid-
holesterol)  micelles  are  not  absorbed  by  the  gallbladder
ucosa,  cholesterol  can  be  absorbed  as  monomers  or  with
hospholipid  vesicles.7--12,24,27--29 The  solubility  of  anhydrous
holesterol  monomers  in  water  is  0.013  nmol/ml;  in  the
ntermicellar  phase  it  is  0.260  nmol/ml,  while  in  the  phos-
holipid  vesicles  it  is  5.5  mol/ml.30--37 Therefore,  it  will  be
bsorbed  with  the  phospholipid  vesicles  to  a  greater  degree
99.9%),  in  accordance  with  the  solubility  of  the  anhydrous
holesterol.  The  phospholipid  vesicles  can  be  absorbed  by
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1
Gallbladder
75%
25%
Ab
so
rp
tio
n
Ab
so
rp
tio
n
a 3
75%
25%
Ab
so
rp
tio
n
Ab
so
rp
tio
n1
2
Gallbladder
b
3
75%
25%
Ab
so
rp
tio
n
1
2
Gallbladder
c
Ab
so
rp
tio
n
3
75%
25%
Ab
so
rp
tio
n
1
Gallbladder
d
Ab
so
rp
tio
n
2
Figure  1  Process  of  gallbladder  bile  formation  in  healthy  humans  from  the  data  of  dynamic  intravenous  cholecystography.  (a)
15--20 min  after  intravenous  instillation  of  contrast;  (b)  30--40  min  after  intravenous  instillation  of  contrast;  (c)  1.5--2.0  h  after
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A
aintravenous instillation  of  contrast;  (d)  2.5--3.0  h  after  intraven
bile; 2  --  non-contrasting  concentrated  gallbladder  bile;  3  --  con
the  gallbladder  mucosa  in  different  ways.7--12,24,27--29 And  so,
the  greater  the  absorption  of  vesicular  cholesterol  by  the
gallbladder  mucosa  is,  the  lower  the  concentration  of  the
cholesterol  in  the  phospholipid  vesicles  of  the  gallbladder
bile.
The  concentration  function  of  the  gallbladder  is  to
accumulate  the  bile  acids  from  the  hepatic  bile  in  the
gallbladder;  it  depends  on  the  rate  that  the  bile  acids
from  the  hepatic  bile  enter  the  gallbladder  and  the  rate
of  water  absorption  by  the  gallbladder  mucosa.  This  func-
tion  also  determines  the  concentration  of  the  total  bile
acids  and  the  formation  of  mixed  biliary  micelles  in  the
gallbladder  bile.  In  the  hepatic  bile  40--80%  of  biliary
cholesterol  is  in  phospholipid  vesicles  and  20--60%  of  it
is  in  mixed  biliary  micelles.35--37 The  gallbladder,  con-
centrating  the  bile  acids,  forms  mixed  biliary  micelles
and  raises  the  level  of  biliary  cholesterol  in  them  up
to  80--100%.35--37 Therefore,  the  greater  the  absorption  of
water  by  the  gallbladder  mucosa  is,  the  greater  the  pas-
sage  of  the  hepatic  bile  acids  to  the  gallbladder,  and  the
higher  the  concentration  of  total  bile  acids  in  the  gallbladder
bile.
Thus,  the  high  concentration  of  the  total  bile  acids  and
the  low  concentration  of  cholesterol  in  phospholipid  vesicles
result  in  the  low  cholesterol  saturation  index  in  the  gall-
bladder  bile  (less  than  1.0),  which  determines  the  stability
of  micellar  carriers  of  biliary  cholesterol  and  prevents  the
cholesterol  monohydrate  crystals  from  precipitating.
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dnstillation  of  contrast.  1  --  Contrasting  unconcentrated  hepatic
ing  concentrated  gallbladder  bile.
ate  of  the  absorbed  vesicular  biliary  cholesterol
art  of  the  absorbed  cholesterol  may  be  esteriﬁed  in  the
pithelial  cells  of  the  gallbladder  mucosa  by  means  of  ACAT.
ormally  the  activity  of  ACAT  makes  up  92  ±  23  pmol/min
er  mg  protein  and  is  8--9  times  as  high  as  that  of  the
iver  microsomes  (11  ±  2  pmol/min  per  mg  protein).38 There
s  a  positive  correlation  between  the  concentration  of
he  cholesterol  in  the  gallbladder  bile  and  ACAT  in  the
icrosomes  of  the  gallbladder  mucosa  (r  =  +0.42,  p  <  0.05).
holesterol  is  also  synthesized  in  the  microsomes  of  the
allbladder  mucosa,  and  the  activity  of  HMG-CoA  reduc-
ase  in  them  makes  up  28  ±  6  pmol/min  per  mg  protein.
ut  it  is  4  times  lower  than  that  of  the  liver  microsomes
120  ±  40  pmol/min  per  mg  protein).  The  concentration
f  free  cholesterol  in  the  microsomes  of  the  gallbladder
ucosa  (206  ±  9  nmol/min  per  mg  protein)  is  4  times  higher
han  that  in  the  liver  microsomes  (55  ±  3  nmol/min  per
g  protein),  while  the  concentration  of  esteriﬁed  choles-
erol  (34  ±  5  nmol/min  per  mg  protein)  is  3.5  times  higher
9  ±  1  nmol/min  per  mg  protein).38 Taking  into  account  the
ow  activity  of  HMG-CoA  reductase  and  the  high  activity  of
CAT  in  the  microsomes  of  the  gallbladder  mucosa,  as  well
s  the  positive  correlation  between  the  level  of  cholesterol
n  the  gallbladder  bile  and  the  microsomes  of  the  gallbladder
ucosa  (r  =  +0.75,  p  <  0.01),  the  higher  concentration  of  free
holesterol  in  the  epithelial  cell  microsomes  of  the  gallblad-
er  mucosa  may  result  only  from  the  excessive  absorption
180  J.L.  Turumin  et  al.
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Figure  2  Exchange  of  cholesterol  in  healthy  humans  (a)  and  patients  after  cholecystectomy  (b).  1  --  gallbladder-dependent
output of  biliary  cholesterol;  2  --  gallbladder-independent  output  of  biliary  cholesterol;  3  --  gallbladder-hepatic  circulation  of
biliary cholesterol;  4  -- hydrolysis  of  cholesterol  esters  that  entered  the  hepatocytes  with  HDL  and  LDL;  5  --  synthesis  of  cholesterol;
6 -- synthesis  of  cholesterol  esters  for  VLDL;  7  --  hydrolysis  of  cholesterol  esters  that  entered  the  hepatocytes  with  CMR.  HMG-
CoA--3-hydroxy-3-methylglutaryl  coenzyme  A  reductase;  HDL,  high  density  lipoprotein;  LDL,  low  density  lipoprotein;  VLDL,  very  low
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tensity lipoprotein;  CMR,  chylomicron  remnants;  Ch,  cholestero
epatic artery;  HV,  hepatic  vein;  PV,  portal  vein;  LD,  lymphatic
f  the  biliary  vesicular  cholesterol.  It  corroborates  the  fact
hat  the  rate  of  the  biliary  vesicular  cholesterol  entering  the
pithelial  cells  of  the  gallbladder  mucosa  is  4  times  greater
han  that  of  the  hepatocytes.
By  analogy  with  the  ileum,  the  removal  of  the  absorbed
esicular  cholesterol  and  phospholipids  from  the  gallblad-
er  wall  may  be  carried  out  by  means  of  HDL  and/or
LDL.39--43 It  was  shown  in  vitro  that  HDL  is  able  to  extract
he  excess  cholesterol  from  the  cholesterol-saturated  phos-
holipid  vesicles  and  dissolve  the  cholesterol  crystals.44,45
t  is  possible  that  the  removal  mechanism  of  the  absorbed
esicular  cholesterol  and  phospholipids  by  means  of  HDL
ay  be  prevalent  and  it  may  be  determined  by  the
oncentration  of  serum  HDL  and  the  rate  of  the  arterial
loodstream  in  the  gallbladder  wall.46,47 In  the  gallbladder
all,  through  its  interrelation  with  phospholipid  vesicles,
DL  will  extract  biliary  vesicular  cholesterol  and  phospho-
ipids  and,  in  the  bloodstream,  they  will  ﬁrst  enter  the
allbladder  vein,  then  the  portal  vein,  and  from  there
hey  will  enter  into  the  liver.  This  supposition  is  indi-
ectly  corroborated  by  the  negative  correlative  connection
etween  CSI  and  the  total  cholesterol  level  (TCh)  (r  =  −0.65,
 <  0.05)  and  serum  Ch-HDL  (r  =  −0.62,  p <  0.05)  in  practi-
ally  healthy  women.48 Small  quantities  of  VLDL  synthesize
n  the  gallbladder  mucosa.49 The  number  of  apoproteins
,  C-II  and  C-III  absorbed  by  the  gallbladder  mucosa  can
ake  up  84--91%  of  the  total  quantity  of  apoproteins  B,
-II  and  C-III,  entering  the  gallbladder  with  the  hepatic
ile.50 In  addition,  taking  into  account  that  the  mucosa  of
he  gallbladder  absorbs  phospholipid  vesicles,  the  apopro-
eins  B,  C-II,  and  C-III  can  interrelate  with  serum  HDL,
DL,  and  VLDL  in  the  gallbladder  wall  below  the  epithe-
ium.
The  absorbed  vesicular  cholesterol  of  the  gallbladder
ucosa,  interrelated  to  blood  lipoproteins,  can  enter  the
iver  or  the  peripheral  bloodstream  through  the  portal  vein
Fig.  2a).
v
c
(
AA,  cholesterol  anhydrous;  ChM,  cholesterol  monohydrate;  HA,
.
We  have  called  the  biliary  cholesterol  path  (blood
lipoproteins]  →  liver  [hepatic  bile  −  phospholipid
esicles]  →  gallbladder  [absorption  of  vesicular  choles-
erol]  →  portal  vein  [lipoproteins]  →  liver  or  blood)  the
‘gallbladder-hepatic  circulation  of  biliary  cholesterol’’
Fig.  2a).
The  detailed  structuring  of  these  processes  provides  an
pportunity  to  connect  the  excretory  function  of  the  liver
nd  the  absorption  and  evacuation  functions  of  the  gallblad-
er  with  the  level  of  serum  cholesterol.
utﬂow  of  biliary  cholesterol  into  the  duodenum
or  understanding  the  processes  of  the  biliary  choles-
erol  outﬂow  into  the  duodenum,  we  have  introduced
wo  new  terms,  namely:  the  gallbladder-dependent  and
allbladder-independent  output  of  biliary  cholesterol.  The
ormer  depends  on  the  ejection  volume  of  the  gallblad-
er  and  the  concentration  of  biliary  cholesterol  in  the
allbladder  bile;  the  latter  depends  on  the  concentration
f  biliary  cholesterol  in  the  hepatic  bile  directly  enter-
ng  the  duodenum  (Fig.  2a).  After  cholecystectomy  only
allbladder-independent  output  of  biliary  cholesterol  to  the
uodenum  is  observed  (Fig.  2b).
nterdependence  between  the  absorption  of  biliary
holesterol  in  the  gallbladder  and  that  of  the  ileum
n  the  gallbladder,  vesicular  cholesterol  absorbs  effectively,
ut  micellar  cholesterol  does  not.7--12,24,27,28 The  absorption
f  micelles  in  the  ileum  is  100  times  more  effective  than
hat  of  vesicles.51 Hence,  the  greater  the  absorption  of
esicular  cholesterol  in  the  gallbladder  is,  the  higher  the
oncentration  of  micellar  cholesterol  in  the  gallbladder  bile
CSI  <  1.0),  and  the  absorption  of  cholesterol  in  the  ileum.
nd  vice  versa,  the  decrease  of  the  vesicular  cholesterol
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Figure  3  Enterohepatic  circulation  of  bile  acids  in  healthy  humans  (a)  and  patients  after  cholecystectomy  (b).  1  --  Gallbladder-
dependent enterohepatic  circulation  of  bile  acids;  2  --  gallbladder-independent  enterohepatic  circulation  of  bile  acids;  3  --  bile
acids entering  the  liver  through  the  hepatic  artery;  4  --  synthesis  of  cholic  acid:  cholesterol-7-hydroxylase;  5  --  synthesis  of
ids  entering  the  liver  through  the  portal  vein.  BA,  bile  acids;  HA,
Table  1  Hydrophilic--hydrophobic  index  (HHI)  of  bile  acids
in mammals52
Bile  acids HHI  of  BA  Mammals
-Hyocholic  acid  (-HCA)  −0.60  Rats
-Muricholic  acid  (-MCA)  −0.51  Rats
-Muricholic  acid  (-MCA)  −0.40  Rats
Murideoxycholic  acid  (МDCA)  −0.33  Rats
Ursodeoxycholic  acid  (UDCA)  −0.17  Bears
-Hyocholic  acid  (-HCA)  −0.03  Pigs
Hyodeoxycholic  acid  (HDCA)  +0.09  Pigs
Cholic acid  (CA)  +0.23  Humans
Chenodeoxycholic  acid  (CDCA)  +0.83  Humans
Deoxycholic  acid  (DCA) +0.98  Humans,
pri-
mates,
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achenodeoxycholic  acid:  cholesterol-27-hydroxylase;  6  -- bile  ac
hepatic artery;  HV,  hepatic  vein;  PV,  portal  vein.
absorption  in  the  gallbladder  raises  the  vesicular  choles-
terol  concentration  in  the  gallbladder  bile  (CSI  more  than
1.0)  and  reduces  the  cholesterol  absorption  in  the  ileum.
The  bile  acids/cholesterol  ratio  in  the  gallbladder  bile  may
determine  the  ability  of  intestinal  mixed  micelles  to  solubi-
lize  dietary  cholesterol.  If  this  ratio  is  higher  than  10--12:1
(CSI  <  1.0),  solubilization  increases,  and  if  it  is  lower  than
7--10:1  (CSI  >  1.0),  solubilization  decreases.
Effect  of  gallbladder  functions  on  the
enterohepatic  circulation
Part  of  the  bile  acids  of  the  hepatic  bile  enters  the  gall-
bladder  and  is  accumulated  in  it;  the  other  part  enters  the
duodenum  and  participates  in  the  enterohepatic  circulation.
To  understand  these  processes,  we  have  introduced  two  new
terms:  gallbladder-dependent  and  gallbladder-independent
enterohepatic  circulation  of  bile  acids  (Fig.  3a).
The  gallbladder-dependent  enterohepatic  circulation  of
bile  acids  depends  on  the  ejection  volume  of  the  gall-
bladder  and  determines  the  bile  acid  concentration  of
the  gallbladder  bile  that  participates  in  the  enterohep-
atic  circulation.  The  gallbladder-independent  enterohepatic
circulation  includes  the  part  of  the  bile  acids  from  the
hepatic  bile  that  directly  enters  the  duodenum,  but  not
the  gallbladder.  In  healthy  people  75--80%  of  bile  acids
participate  in  the  gallbladder-dependent  enterohepatic  cir-
culation,  and  only  20--25%  of  bile  acids  take  part  in  the
gallbladder-independent  circulation  (Fig.  3a).  Therefore,
the  concentration  function  of  the  gallbladder  is  to  accumu-
late  the  bile  acids  from  the  hepatic  bile  and  exclude  them
from  the  enterohepatic  circulation.  The  part  of  the  bile
acids  participating  in  the  gallbladder-independent  entero-
hepatic  circulation  after  cholecystectomy  increases  up  to
100%  (Fig.  3b).  Detailed  structuring  of  these  processes
enables  the  absorption,  concentration,  and  evacuation
functions  of  the  gallbladder  to  be  connected  with  the
enterohepatic  circulation  of  the  bile  acids.  The  rate  at  which
water  is  absorbed  by  the  gallbladder  mucosa  determines  the
T
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(rabbits
Lithocholic  acid  (LCA)  +1.23  Humans
assive  passage  of  the  hepatic  bile  from  the  liver  into  the
allbladder  and  the  gallbladder-independent  enterohepatic
irculation  of  the  bile  acids.
haracteristics of bile acids
ccording  to  the  hydrophilic-hydrophobic  index,  the  bile
cids  are  divided  into  hydrophilic  and  hydrophobic  ones
Table  1).3,52,53
If  the  hydrophobic  index  is  less  than  that  of  cholic
cid  (CA),  the  bile  acids  are  hydrophilic;  if  it  is  more
han  the  hydrophobic  index,  they  are  hydrophobic.3,52,53
he  primary  bile  acids  are  more  hydrophilic  than  the
econdary  ones,  but  the  taurine  conjugates  of  the  bile
cids  are  more  hydrophilic  than  the  glycine  ones.3,52,53he  hydrophilic  bile  acids  have  hepatoprotective  proper-
ies  (muricholic  [MCA]  >  ursodeoxycholic  [UDCA]  >  cholic
CA]).54,55 The  hydrophobic  bile  acids  are  hepatotoxic
lithocholic  [LCA]  >  deoxycholic  [DCA]  >  chenodeoxycholic
1 J.L.  Turumin  et  al.
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Table  2  Presence  of  gallbladder  and  type  of  bile  acids.
Mammals  Presence  of
gallbladder
Type  of  bile  acids  or  bile
alcohols
Rats  No  Hydrophilic  bile  acids
Camels  No  ?
Deer  No  ?
Elephants  No  Hydrophilic  bile  alcohols
Rhinoceros  No  Hydrophilic  bile  alcohols
Whales  No  Hydrophilic  bile  alcohols
Bears Yes  Hydrophilic  bile  acids
Rabbits  Yes  Hydrophobic  bile  acids
Primates  Yes  Hydrophilic  and
hydrophobic  bile  acids
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CDCA]  >  CA).3,52--57 Depending  on  the  concentra-
ion,  the  hydrophobic  bile  acids  cause  cholestasis
LCA  > DCA),  necrosis  (LCA  >  DCA),  or  apoptosis  of  hepa-
ocytes  (LCA  >  DCA  >  CDCA).52--57 Furthermore,  DCA  is
ancerogenic.58 Experiments  on  animals  showed  that  it
auses  cancer  of  the  colon.59 The  hydrophilic  bile  acids  pre-
ent  the  development  of  cholestasis  or  necrosis/apoptosis
f  hepatocytes  (UDCA,  MCA),  as  well  as  cancer  of  the  colon
UDCA).54--57,59
In  serum  up  to  40%  of  bile  acids  are  transported  with
DL  and  up  to  15%  are  transported  with  LDL.2 The  bind-
ng  mechanism  of  bile  acids  with  lipoproteins  depends
n  their  hydrophobic  index  (CDCA  >  DCA  >  UDCA  >  CA  >  7-
picholic  acid).2 In  the  liver,  there  is  a  60--80%  bile  acid
ptake  during  one  passage  of  portal  blood.60 In  earlier
xperiments  on  hamsters,  it  was  demonstrated  that  the
epatic  LDL  uptake  could  inﬂuence  the  bile  ﬂow  rate  and
he  biliary  secretion  of  bile  acids  and  cholesterol.61,62 The
omposition  and  concentration  of  bile  acids  participating
n  the  enterohepatic  circulation  can  modulate  the  LDL
eceptor  activity  and  the  receptor-dependent  LDL  uptake
n  the  liver.  An  increase  in  hydrophilic  UDCA  stimulates
he  receptor-dependent  LDL  uptake  in  the  liver,  but  more
ydrophobic  CDCA  decreases  the  LDL  receptor  activity.61,62
t  was  also  shown  that  the  addition  of  hydrophobic  CDCA
o  a  hypercholesterolemic  diet  reduces  the  decrease  of
erum  HDL  concentration,  but  the  addition  of  hydrophilic
DCA  has  the  opposite  effect.63,64 In  hepatocytes,  the  bile
cids  may  inhibit  the  activity  of  HMG-CoA  reductase  and
holesterol-7-hydroxylase,  depending  on  their  concentra-
ion  and  hydrophobic  index  (DCA  >  CDCA  >  CA  >  UDCA).52,65--67
The  hydrophilic  bile  acids  stimulate  the  secretion  of  the
epatic  bile  (UDCA  >  CA)  and  the  hydrophobic  ones  lower  it
LCA  > DCA  >  CDCA).68--70 UDCA  and  CDCA  reduce  the  secre-
ion  of  biliary  cholesterol  in  the  hepatic  bile,  but  CA  and
CA  raise  it.3,68--70 In  the  gallbladder  bile,  the  hydrophobic
ile  acids  form  mixed  and  simple  micelles  (DCA  >  CDCA  >  CA),
ut  the  hydrophilic  bile  acids  form  liquid  crystalline  lamellas
MCA  >  UDCA);  in  other  words,  the  lower  the  hydropho-
ic  index  of  bile  acids,  the  lower  the  ability  to  form
icelles.71--73 In  the  ileum,  CA  and  CDCA  raise  the  absorption
f  cholesterol,  but  UDCA  and  DCA  reduce  it.74--77
During  the  process  of  enterohepatic  circulation  in  the
leum  and  the  colon,  anaerobic  bacteria  promote  7-
ehydroxylation  of  the  primary  bile  acids  (hyocholic  acid
HCA],  MCA,  CA,  CDCA)  and  the  formation  of  the  secondary
ile  acids  (hyodeoxycholic  acid  [HDCA],  murideoxycholic
cid  [MDCA],  DCA,  LCA).3,52,78,79 The  secondary  bile  acids
re  more  hydrophobic  than  the  primary  ones  (HDCA  >  HCA,
DCA  >  MCA,  DCA  >  CA,  LCA  >  CDCA).3,52,53 The  secondary  bile
cids  are  usually  poorly  absorbed  in  the  ileum  and  the  colon
nd  are  excreted  with  feces.3,52,53
he protective role of the gallbladder
ammalsn  mammals  (rats)  that  do  not  have  a  gallbladder,  only  the
ydrophilic  hepatoprotective  bile  acids  are  synthesized;  as
or  the  secondary  hydrophobic  hepatotoxic  bile  acids,  they
i
e
p
iHumans  Yes  Hydrophilic  and
hydrophobic  bile  acids
re  formed  in  small  quantities  or  are  poorly  absorbed  in  the
leum  and  the  colon  (Table  2).
Since  a  long  stagnation  period  in  the  gallbladder  is
hought  to  promote  the  formation  of  gallstones,  the  gall-
ladder  may  be  absent  in  mammals  that  can  manage  without
ood  and  water  for  long  periods  of  time  (camels,  deer).4
ince  the  size  of  the  gallbladder  must  be  proportional  to
he  size  of  the  liver,  the  gallbladder  may  be  absent  in
ig  mammals  (elephants,  rhinoceros,  whales)  because  of
heir  anatomical  peculiarities.4 In  these  mammals  there  is
 considerable  synthesis  of  bile  alcohols,  which  are  poorly
olubilized  cholesterol.2 In  mammals  that  have  a  gallblad-
er  (humans,  monkeys,  rabbits),  both  the  hydrophilic  and
ydrophobic  bile  acids  may  be  synthesized.  The  secondary
ydrophobic  hepatotoxic  bile  acids  can  be  formed  in  large
uantities,  but  they  are  poorly  absorbed  in  the  ileum  and
he  colon.2--4 Since  a  long  stagnation  period  in  the  gall-
ladder  may  promote  the  formation  of  gallstones,  only  the
ydrophilic  bile  acids  are  synthesized  in  mammals  that  have
ong  periods  of  hibernation  (bears),  but  the  secondary  bile
cids  are  also  hydrophilic.2--4
Therefore,  the  basic  role  of  the  gallbladder  in  mammals
n  which  hydrophobic  hepatotoxic  bile  acids  are  synthesized
r  formed,  is  the  protection  of  the  liver  from  their  effect
y  means  of  bile  acid  accumulation  in  the  gallbladder  and
owering  the  number  of  enterohepatic  circulation  cycles.
he  mammals  in  which  the  hydrophobic  hepatotoxic  bile
cids  are  synthesized  or  formed  must  have  a  gallbladder.
hose  mammals  in  which  the  hydrophilic  hepatoprotective
ile  acids  are  synthesized  and  the  hydrophobic  hepatotoxic
ile  acids  are  formed  in  small  quantities,  may  manage  with-
ut  one.  The  mammals  in  which  bile  alcohols  are  synthesized
n  large  amounts,  do  not  have  a  gallbladder.
umans
n  humans,  the  formation  of  cholesterol  gallstones  is  pro-
oted  by  a  decrease  in  absorption  (a  decrease  in  water  and
hospholipid  vesicle  absorption),  concentration  (a  decrease
n  total  bile  acid  concentration  in  gallbladder  bile),  and
vacuation  (a  decrease  in  the  gallbladder-dependent  out-
ut  of  biliary  cholesterol)  functions  and  by  an  increase
n  the  gallbladder’s  secretion  function  (hypersecretion  of
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Figure  4  Cholesterol  exchange  in  patients  with  chronic
acalculous  cholecystitis  and  chronic  calculous  cholecystitis.
1 -- gallbladder-dependent  output  of  biliary  cholesterol;  2
-- gallbladder-independent  output  of  biliary  cholesterol;  3
-- gallbladder-hepatic  circulation  of  biliary  cholesterol;  4  --
hydrolysis  of  cholesterol  esters  that  entered  the  hepatocytes
with HDL  and  LDL;  5  -- synthesis  of  cholesterol;  6  --  synthesis  of
cholesterol  esters  for  VLDL;  7  --  hydrolysis  of  cholesterol  esters
that entered  the  hepatocytes  with  CMR.  ChA,  cholesterol  anhy-
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Figure  6  Exchange  of  cholesterol  and  bile  acids  in  patients
with  chronic  acalculous  cholecystitis  and  chronic  calculous
cholecystitis.  1  -- synthesis  of  cholesterol;  2  --  synthesis  of
cholesterol  esters  for  VLDL;  3  --  hydrolysis  of  cholesterol  esters
that entered  the  hepatocytes  with  HDL  and  LDL,  and  hydrolysis
of cholesterol  esters  that  entered  the  hepatocytes  with  CMR;  4  --
synthesis  of  bile  acids.  ChE,  cholesterol  esters;  ChA,  cholesterol
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of  the  gallbladder-independent  enterohepatic  circulation  of
bile  acids.drous;  ChM,  cholesterol  monohydrate;  HA,  hepatic  artery;  HV,
hepatic vein;  PV,  portal  vein;  LD,  lymphatic  duct.
glycoprotein  mucin  by  the  gallbladder  mucosa)  (Fig.  4).80 A
decrease  in  the  rate  of  water  absorption  in  the  gallbladder
wall  limits  the  ‘‘passive’’  passage  of  the  hepatic  bile  into
the  gallbladder  and  increases  the  hepatic  bile  passage  into
the  duodenum  (Fig.  5).6,24,80 A  decrease  in  the  evacuation
function  of  the  gallbladder  reduces  the  ‘‘active’’  passage
of  the  hepatic  bile  into  the  gallbladder.81,82 This  process  is
accompanied  by  a  decrease  in  the  total  bile  acid  concentra-
tion  and  an  increase  in  the  biliary  cholesterol  concentration
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Figure  5  ‘‘Active’’  and  ‘‘passive’’  passage  of  hepatic  bile
into the  gallbladder  and  into  the  duodenum  in  patients  with
chronic  calculous  cholecystitis.  1  --  Unconcentrated  hepatic
bile; 2  --  low  concentrated  gallbladder  bile  with  gallstones.
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Hnhydrous;  ChM,  cholesterol  monohydrate;  BA,  bile  acids;  HA,
epatic artery;  HV,  hepatic  vein;  PV,  portal  vein;  LD,  lymphatic
uct.
n  phospholipid  vesicles  and  it  also  promotes  an  increase  in
he  amount  of  time  needed  for  the  precipitation  of  choles-
erol  monohydrate  crystals  and  the  formation  of  cholesterol
allstones  (Fig.  6).83--87 The  excessive  hepatic  bile  passage
rom  the  liver  into  the  duodenum  increases  the  frequencyThe  gallbladder-independent  enterohepatic  circulation
f  bile  acids  in  patients  with  cholesterol  gallstone  disease
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igure  7  Enterohepatic  circulation  of  bile  acids  in  patients
ith chronic  calculous  cholecystitis.  1  --  Gallbladder-dependent
nterohepatic  circulation  of  bile  acids;  2  --  gallbladder-
ndependent  enterohepatic  circulation  of  bile  acids;  3  --  bile
cids  entering  the  liver  through  the  hepatic  artery;  4  --  syn-
hesis of  cholic  acid:  cholesterol-7-hydroxylase;  5  --  synthesis
f chenodeoxycholic  acid:  cholesterol-27-hydroxylase;  6  --  bile
cids entering  the  liver  through  the  portal  vein.  BA,  bile  acids;
A, hepatic  artery;  HV,  hepatic  vein;  PV,  portal  vein.
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Table  3  Percentage  of  hydrophobic  DCA  in  the  bile  of
rabbits,  primates  and  humans.
Mammals  %  of  DCA
Rabbits  Up  to  90%
Primates  Up  to  50%
Humans  (healthy)  Up  to  10--20%
Humans  (patients  with  gallstone  disease)  Up  to  25--40%
Humans  (after  cholecystectomy)  Up  to  25--60%
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Figure  8  Exchange  of  cholesterol  and  bile  acids  in  healthy
humans.  1  --  synthesis  of  cholesterol;  2  --  synthesis  of  choles-
terol  esters  for  VLDL;  3  --  hydrolysis  of  cholesterol  esters  that
entered  the  hepatocytes  with  HDL  and  LDL,  and  hydrolysis  of
cholesterol  esters  that  entered  the  hepatocytes  with  CMR;  4  --
synthesis  of  bile  acids.  ChE,  cholesterol  esters;  ChA,  cholesterol
anhydrous;  ChM,  cholesterol  monohydrate;  BA,  bile  acids;  HA,
hepatic artery;  HV,  hepatic  vein;  PV,  portal  vein;  LD,  lymphatic
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trends  in  their  treatment  and  prevention  and  to  anticipateCGD)  or  after  cholecystectomy  is  increased  (Figs.  3b  and  7).
t  results  in:  (1)  an  increase  in  the  hydrophobic  hepatotoxic
CA  formation  and  its  accumulation  in  hepatocytes,  (2)  the
ormation  of  morphological  changes  in  the  liver  (non-speciﬁc
eactive  hepatitis),  and  (3)  the  appearance  of  cholestasis
Table  3).26,88,89
The  risk  of  cancer  of  the  liver,  the  pancreas,  the
mall  intestine,  and  the  colon  increases  as  well.58,90--97
he  increases  in  DCA,  participating  in  the  enterohep-
tic  circulation,  and  other  toxic  agents  in  the  hepatic
ile  can  result  in  chronic  pancreatitis  and  duodenogastric
eﬂux.98--101
Hence,  the  basic  role  of  the  gallbladder  in  humans
s  a  protective  one.  The  gallbladder  decreases  the  for-
ation  of  the  secondary  hydrophobic  hepatotoxic  bile
cids  (DCA  and  LCA)  by  accumulating  the  primary  bile
cids  (CA  and  CDCA)  in  the  gallbladder  and  by  redu-
ing  their  concentration  in  the  gallbladder-independent
nterohepatic  circulation,  thereby  protecting  the  liver,  the
ucosa  of  the  stomach,  the  gallbladder,  and  the  colon
rom  their  effect.  In  addition,  the  increase  in  the  entero-
epatic  circulation  cycles  in  humans  can  determine  the
reater  enterohepatic  circulation  of  estrogens,  proges-
erones,  and  the  formation  of  their  active  metabolites:
.  (a)  16-hydroxyestrone  (it  activates  proliferation  and
nduces  breast  cancer),  (b)  4-hydroxyestrone  (prolifera-
ion,  cancer),  and  (c)  2-hydroxyestrone  (it  stimulates  fat
ccumulation  in  the  human  body);  2.  (a)  pregnenolone
inﬂammation,  cholestasis)  and  (b)  pregnanediol  (inﬂamma-
ion,  cholestasis).102--105
The  excessive  formation  of  these  ‘‘active’’  metabolites
nd  DCA  most  likely  determines  the  increased  risk  of  can-
er  in  various  sites.96,97 A  total  of  9.4%  of  the  patients
ith  gallstones  and  cholecystectomized  patients  have  pre-
ented  with  cancer  at  different  sites  (cancer  of  the  liver,
he  pancreas,  the  colon,  and  the  small  intestine,  and  breast
ancer  in  women).96,97 For  women  who  underwent  chole-
ystectomy  under  the  age  of  50  (i.e.  before  menopause),
he  risk  of  colon  cancer  was  higher  than  for  those  who
nderwent  cholecystectomy  above  the  age  of  50.90 Estro-
ens  intensify  the  cancer  effect  of  hydrophobic  DCA.106 The
oncentration  of  total  bile  acids  in  blood  serum  is  3  times
igher  and  the  risk  of  intrahepatic  cholestasis  is  2.5  times
igher  in  cholecystectomized  pregnant  women  (19%)  than  in
on-cholecystectomized  pregnant  women.107 Children  born
ithout  a  gallbladder  have  liver  function  disturbances  and
ag  behind  in  physical  development.26 It  would  have  been
xtremely  difﬁcult  for  humans  to  have  evolved  without  a
allbladder.
t
puct.
he role of the gallbladder and gallbladder
ile in digestion
he  evacuation  volume  of  the  gallbladder  depends  on  the
uality  and  quantity  of  accepted  food.  The  gallbladder  is
mptied  to  a  greater  extent  when  fatty  food  is  accepted.4
ince  the  gallbladder  contracts  in  5--20  min  after  food  is
vailable  in  the  stomach,  and  ‘‘the  gastric  chyme’’  moves
rom  the  stomach  into  the  duodenum  only  1--3  h  later,  the
ole  of  the  gallbladder  bile  in  digestion  may  be  insigniﬁcant.
he  gallbladder  bile,  coming  into  the  duodenum,  stimulates
ntestinal  peristalsis  and  promotes  the  cleaning  of  the  intes-
ine  for  ‘‘a  new  gastric  chyme’’.
The  hepatic  and  gallbladder  bile  volumes  and  the  bile
cid  concentration,  participating  in  the  ﬁrst  full  cycle
f  gallbladder-dependent  and  gallbladder-independent
nterohepatic  circulation,  determine  the  bile  acid-
timulated  secretion  of  the  hepatic  bile  that  participates
o  a greater  extent  in  digestion.
onclusion
hus,  the  basic  role  of  the  gallbladder  in  humans  is  to  pro-
ect  the  liver,  the  mucosa  of  the  stomach,  the  gallbladder,
nd  the  colon  from  the  effect  of  hepatotoxic,  hydropho-
ic  bile  acids,  as  well  as  to  regulate  the  serum  lipid  level
Fig.  8).1--3,52--56,59,108,109
This  gallbladder  bile  formation  model  provides  a  bet-
er  understanding  of  the  causes  of  the  diseases  of  the
epatobiliary  zone.  It  also  allows  us  to  visualize  varioushe  appearance  of  various  disorders  in  the  hepato-biliary-
ancreatic-duodenal-gastric  region  after  cholecystectomy.
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